| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2007 | US7235587 E.g., 3-((2E)-2-cyano-3,3-diphenylprop-2-enoyloxy)-2,2-dimethylpropyl 4-((2Z)-2-cyano-3,3-diphenylprop-2-enoyloxy)-2,2-dimethylbutyl (2E)but-2-ene-1,4-dioate); especially for stabilizing dibenzoylmethane sunscreens |
| 06/26/2007 | US7235586 prostaglandin derivatives such as (Z)-7-((1R,2S,3R)-2-Butylcarbamoyloxymethyl-3-hydroxy-5-oxo-cyclopentyl)-hept-5-enoic acid methyl ester, administering to mammals for treatment of ocular hypertension; hypotensive agents |
| 06/26/2007 | US7235584 Dibenzo[b,d]pyran derivatives as neuroprotectant, antiinflammatory, and antiischemic agents; brain, cardiovascular, neurodegenerative, autoimmune and nervous system disorders; Grave*s, Hashimoto*s, Alzheimer*s, Parkinson*s, and Huntington*s disease; amyotrophic lateral sclerosis; drug abuse, alcoholism |
| 06/26/2007 | US7235583 Amount of the conjugate in the container is at least 30% on a molar basis greater than the maximum tolerated dose (MTD) in the subject for the unconjugated anticancer compound; e.g., docosahexaenoic acid/paclitaxel or docetaxel conjugate; for intravenous administration |
| 06/26/2007 | US7235582 Basic salt of thioctic acid with L-carnitine |
| 06/26/2007 | US7235581 For therapy of Alzheimer's disease |
| 06/26/2007 | US7235580 Mitotic kinesin inhibitors |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235578 Used as cytotoxins for cancer therapy and as prodrugs for gene-directed enzyme-prodrug therapy and antibody-directed enzyme-prodrug theraphy |
| 06/26/2007 | US7235577 Administering a (halophenyl)diphenylmethyl-1H-pyrazole to inhibit calcium activated potassium channels encoded by IKCa1 without causing substantial inhibition of cytochrome P-450 enzymes; immunosuppressive treatment of autoimmune disorders, graft rejection and/or graft/host disease |
| 06/26/2007 | US7235576 Inorganic or organic acid salts or basic salts of sorafenib; e.g. sorafenib tosylate; cancer of the lung, pancreas, thyroid, bladder or colon |
| 06/26/2007 | US7235575 Guanidine mimics as factor Xa inhibitors |
| 06/26/2007 | US7235574 Pentafluorosulfanyl compounds |
| 06/26/2007 | US7235573 Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
| 06/26/2007 | US7235572 Thiazolyl-indole derivatives, their manufacture and use as pharmaceutical agents |
| 06/26/2007 | US7235571 Insecticides; for human or veterinary medicine |
| 06/26/2007 | US7235570 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 06/26/2007 | US7235569 5-HT1A receptor antagonists and serotonin uptake inhibitors; increasing levels of serotonin in synapse and reducing latency period; psychological disorders |
| 06/26/2007 | US7235568 N-dihydrobenzofuran-7-yloxyethyl-substituted, e.g., [2-(2,2-Dimethyl-2,3-dihydrobenzofuran-7-yl-oxy)ethyl]-(5-cyclopenten-1-ylpyridin-3-ylmethyl)amine; benzofuran ring may 2-spirocyclopropyl- or 2-spirocyclobutyl-substituted |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235566 Pyridinone derivatives for treatment of atherosclerosis |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235564 11'-substituted; potent inhibitors of cellular mitosis and proliferation |
| 06/26/2007 | US7235563 N-phenyl-or pyridyl-8-azaspiro(4,5)decane-7,9-diones, e.g., 5-(7,9-Dioxo-8-aza-spiro[4.5]dec-8-yl)-quinoline-8-carbonitrile; used for the treatment of nuclear hormone receptor-associated conditions such as cancer |
| 06/26/2007 | US7235562 5-trifluoromethyl-N2-indolyl- and quinolinyl-substituted-2,4-pyrimidinediamines, e.g., N2-[3-(1,2,3,6-Tetrahydro-pyridin-4-yl)-1H-indol-5-yl]-N4-p-tolyl-5-trifluoromethyl-pyrimidine-2,4-diamine and -[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-3,4-dihydro-1H-quinolin-2-one |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235560 Pyrimidine derivative as selective COX-2 inhibitors |
| 06/26/2007 | US7235559 Therapeutic quinazoline derivatives |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235556 triazolo[1,5,b]pyridazine and imidazo[1,2,b]pyridazine derivatives, especially for treating symptoms of dry eye associated with refractive surgery. |
| 06/26/2007 | US7235555 Indolylmaleimide derivatives |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235551 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 06/26/2007 | US7235550 Polycyclic azaindole compounds |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235548 Central nervous system disorders; cognition activators; Alzheimer's disorders; stroke |
| 06/26/2007 | US7235547 Pharmaceutical composition comprising an AChE inhibitor and a mGluR2 antagonist |
| 06/26/2007 | US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 06/26/2007 | US7235545 (Calcitonin gene related peptide); azepinone ligands; migranes; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 06/26/2007 | US7235544 for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease |
| 06/26/2007 | US7235543 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 06/26/2007 | US7235542 Diagnosis and treatment of human kidney diseases |
| 06/26/2007 | US7235540 Anticancer agents; substantially free of steroid contaminants having estrogenic or carcinogenic effects; |
| 06/26/2007 | US7235539 6-Hydroxyequilenins as estrogenic agents |
| 06/26/2007 | US7235538 Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
| 06/26/2007 | US7235537 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 06/26/2007 | US7235536 Administering sulfated polysaccharide such as cellulose sulfate, dextran sulfate, dermatan sulfate, chondroitin sulfate, pentosan sulfate, fucoidin, mannan sulfate, dextrin sulfate, curdlan sulfate, chitin sulfate, heparin or heparin sulfate for therapy and prophylaxis of fungal infection |
| 06/26/2007 | US7235535 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 06/26/2007 | US7235533 Compounds and their uses |
| 06/26/2007 | US7235523 Methods for the treatment of hepatic disorders |
| 06/26/2007 | US7235392 Transforming B lymphocytes with Epstein-Barr virus, incubating transformed B lymphocytes with flavin N-oxide photosensitizer, adding non-toxic antioxidant, and exposing lymphocytes to activator such as photoradiation to activate photosensitizer |
| 06/26/2007 | US7235390 Mixture of Aspergillus derived protease, lipase, amylase and cellulase, and calcium, zinc, manganese, and magnesium cofactors; improved digestion |
| 06/26/2007 | US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 06/26/2007 | US7235371 Human osteoclast derived cathepsin |
| 06/26/2007 | US7235370 Site-specific aminoglycoside derivatives for use in immunodiagnostic assays |
| 06/26/2007 | US7235363 Detecting modulators of brain membrane protein; obtained membrane protein incubated with ligand and labeled compound, measure level of binding |
| 06/26/2007 | US7235268 With a starch-free soluble fiber of Musa spp. fruit such as plantains or bananas |
| 06/26/2007 | US7235267 Brain cell or nerve cell-protecting agents comprising medicinal ginseng |
| 06/26/2007 | US7235260 Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor |
| 06/26/2007 | US7235259 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 06/26/2007 | US7235257 Drugs for relieving hemicrania comprising 1-menthol and essential oils |
| 06/26/2007 | US7235256 administering a lactating animal during dry period, in a suitable form for peroral administration, a calcium-binding compound such as polysaccharide, effective to reduce the absorption of calcium from the drinking water and/or from the ration of such animal; natural calcium regulating mechanisms |
| 06/26/2007 | US7235255 a fibrinogen component; a thrombin component, anda corticosteroid such as betamethasone containing solution; improved fibrin sealant; |
| 06/26/2007 | US7235251 Cosmetic or dermatological oil/water emulsions with reduced lipid content |
| 06/26/2007 | US7235247 Aqueous solution; efficient penetration |
| 06/26/2007 | US7235243 Immunological combination compositions and methods |
| 06/26/2007 | US7235238 Antibodies that bind receptor protein designated 2F1 |
| 06/26/2007 | US7235237 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 06/26/2007 | US7235236 A replication-defective adenoviral or adeno-associated viral vector; gene therapy for congestive heart failure |
| 06/26/2007 | US7235233 Fiber protein of seretype 11, 16, 35, 40 and/or 51; efficient transduction; nucleic acid transfer |
| 06/26/2007 | US7235230 Leave-on compositions for personal care |
| 06/26/2007 | CA2455231C Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 06/26/2007 | CA2379605C Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 06/26/2007 | CA2368634C P-boronophenylalanine complexes with fructose and related carbohydrates and polyols |
| 06/26/2007 | CA2349930C Bioactive prostheses with immunosuppressive, antistenotic and antithrombotic properties |
| 06/26/2007 | CA2339356C Prostate formula |
| 06/26/2007 | CA2307792C Method for regulating size and growth of vascularized normal tissue |
| 06/26/2007 | CA2269921C Ionophore-mediated liposome loading of weakly basic drug |
| 06/26/2007 | CA2244268C Nucleoside analogs in combination therapy of herpes simplex infections |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2216827C Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 06/26/2007 | CA2200516C Benzopyran derivative and method for treating heart disease using said benzopyran derivative |
| 06/26/2007 | CA2197176C Use of selegiline for the treatment of epileptic disorders |
| 06/26/2007 | CA2185037C Iridaceae extract and compositions containing the same |
| 06/26/2007 | CA2155014C Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups |
| 06/23/2007 | CA2571800A1 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 06/22/2007 | CA2550417A1 Method for maintaining cerebral hemispheric oxygen saturation during surgery |
| 06/21/2007 | WO2007070892A2 Useful indole compounds |
| 06/21/2007 | WO2007070872A1 Kinase inhibitors and their uses |
| 06/21/2007 | WO2007070866A2 Control of intraocular pressure using alk5 modulation agents |
| 06/21/2007 | WO2007070865A2 Piperazine compounds as agonists of trpv4 channel receptors |
| 06/21/2007 | WO2007070840A2 Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 06/21/2007 | WO2007070834A2 Controlling toxicity of aminoquinoline compounds |
| 06/21/2007 | WO2007070818A1 Six-membered heterocycles useful as serine protease inhibitors |
| 06/21/2007 | WO2007070801A2 Methods and systems for preparing antimicrobial films and coatings |
| 06/21/2007 | WO2007070796A1 Azepinoindole derivatives as pharmaceutical agents |
| 06/21/2007 | WO2007070795A2 Broad spectrum non-traditional preservative system |
| 06/21/2007 | WO2007070779A2 A method to treat premature ejaculation in humans |
| 06/21/2007 | WO2007070703A2 Sinomenine derivatives and preparation and uses thereof |